Abound Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310 | Buy |
20
+4
| +25% | +$62 | ﹤0.01% | 916 |
|
|
2025
Q1 | $238 | Sell |
16
-28
| -64% | -$417 | ﹤0.01% | 928 |
|
|
2024
Q4 | $583 | Hold |
44
| – | – | ﹤0.01% | 782 |
|
|
2024
Q3 | $626 | Hold |
44
| – | – | ﹤0.01% | 827 |
|
|
2024
Q2 | $570 | Hold |
44
| – | – | ﹤0.01% | 791 |
|
|
2024
Q1 | $612 | Hold |
44
| – | – | ﹤0.01% | 839 |
|
|
2023
Q4 | $628 | Sell |
44
-76
| -63% | -$1.09K | ﹤0.01% | 867 |
|
|
2023
Q3 | $1.85K | Hold |
120
| – | – | ﹤0.01% | 628 |
|
|
2023
Q2 | $1.88K | Buy |
120
+40
| +50% | +$627 | ﹤0.01% | 656 |
|
|
2023
Q1 | $1.31K | Hold |
80
| – | – | ﹤0.01% | 622 |
|
|
2022
Q4 | $1.24K | Buy |
80
+2
| +3% | +$31 | ﹤0.01% | 595 |
|
|
2022
Q3 | $1.02K | Buy |
+78
| New | +$1.02K | ﹤0.01% | 606 |
|